The FDA asked three major companies to recall their blood pressure medication because of the impurities that could possibly lead to cancer. The medication had an ingredient called valsartan to treat the condition. The culprit here is NDMA which the valsartan drug may contain and is a potential cause of possible cancer risk to the consumers of those drugs.
Blood pressure control is key to healthy human body functioning and medicine that controls it should not have a risk of cancer.
Please contact us at our office located in Queens, NY at 718-509-6181 for a free case evaluation. Please take notice that this is not legal advice. This is an advertisement. If you need legal advice, please contact Bhurtel Law Firm.
Published: August 18, 2019 | Sources: Bhurtel Law Firm, FDA
Tags: Blood Pressure Medicine & Cancer, Blood Pressure Medicine Lawyer, Cancer due to Medicine Lawyer NYC, Medical Malpractice Lawyer, Medical Malpractice Plaintiff Lawyer, Valsartan Recall, Valsartan Recall Lawyer